CK Aspire attending Evidence Europe 2017

We are attending Evidence Europe at the Victoria Park Plaza in London on the 22-23rd of February. For those of you who have not come across the Evidence series of conferences, they are one of the worlds premier Real-World Evidence conferences featuring many thought leaders from across the industry.

Continue reading

Evidence Europe 2017 logo

Why Real-World Evidence

In a recent edition of ‘Trends’ entitled ‘Real-World Evidence Revolution’, Paul Simms (Chairman of eyeforpharma) articulated a thought I have had running through my head for a while now:

“… the health economy is changing fast, moving from measuring inputs (e.g. number of patients seen, pills sold ect.) to outputs (most importantly, patient outcomes).”

Continue reading

Microscope

CK Aspire is shortlisted for Nursing Times Awards

CK Aspire submitted an entry into the Nursing Times Awards for our Domiciliary Research Team involved in the Salford Lung Study earlier this year. The short list has been announced and it’s fantastic to say that their entry has been shortlisted in the clinical research nursing category.

Continue reading

Clinical Business Development Manager

CK Aspire are recruiting for a Clinical Business Development Manager to join our growing team working in the field of Real World Evidence and Clinical Development. This is a permanent role and can be based in Stevenage, Manchester, Chesterfield or potentially field based.

CK Aspire are a leading CRO in the world of pragmatic Real World Evidence studies and have been heavily involved in the highly publicised Salford Lung Study.

Continue reading

Colourful pills